Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide

Obstetrics and Gynecology

Volumn 76, Issue 6, 1990, Pages 1020-1024

  Morris, Mitchell ^a   Gershenson, David M ^a   Burke, Thomas W ^a   Kavanagh, John J ^a   Silva, Elvio G ^a   Wharton, J Taylor ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYSTITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; OTOTOXICITY; OVARY; PRIORITY JOURNAL; UTERINE TUBE CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FALLOPIAN TUBE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, INTRAVENOUS; MIDDLE AGE; NEOPLASM STAGING; REMISSION INDUCTION; SURVIVAL RATE;

EID: 0025201388     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hanton EM, Malkasian GD. Dahlin DC, Pratt JH. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1966;94:832-9.
2. Pfeiffer P, Mogensen H, Amtrup F, Honore E. Primary carcinoma of the fallopian tube. A retrospective study of patients reported to the Danish Cancer Registry in a five-year period. Acta Oncol 1989;28:7-11.
3. Harrison CR, Averette HE, Jarrell MA, Penalver MA, Donato D, Sevin BU. Carcinoma of the fallopian tube: Clinical management. Gynecol Oncol 1989;32:357-9.
4. Hirai Y, Kaku S, Teshima H, et al. Clinical study of primary carcinoma of the fallopian tube: Experience with 15 cases. Gynecol Oncol 1989;34:20-6.
5. King A, Seraj IM, Thrasher T, Slater J, Wagner RJ. Fallopian tube carcinoma: A clinicopathological study of 17 cases. Gynecol Oncol 1989;33:351-5.
6. Peters WA, Anderson WA, Hopkins MP. Results of chemotherapy in advanced carcinoma of the fallopian tube. Cancer 1989;63: 836-8.
7. Maxson WZ, Stehman FB, Ulbright TM, Sutton GP, Ehrlich CE. Primary carcinoma of the fallopian tube: Evidence for activity of cisplatin combination therapy. Gynecol Oncol 1987;26:305-13.
8. McMurray EH, Jacobs AJ, Perez CA, Camel HM, Kao MS, Galakatos A. Carcinoma of the fallopian tube. Management and sites of failure. Cancer 1986;58:2070-5.
9. Podratz KC, Podczaski ES, Gaffey TA, O’Brien PC, Schray MF, Malkasian GDJ. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1986;154:1319-26.
10. Eddy GL, Copeland LJ, Gershenson DM, Atkinson EN, Wharton JT, Rutledge FN. Fallopian tube carcinoma. Obstet Gynecol 1984;64:546-52.
11. Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the uterine tube. Am J Obstet Gynecol 1950;59:58-67.
12. Dodson MG, Ford JH, Averette HE. Clinical aspects of fallopian tube carcinoma. Obstet Gynecol 1970;36:935-9.
13. SPSS-X: Statistical package for the social sciences. 3rd ed. New York: McGraw-Hill, 1988.
14. Smith JP, Delgado G, Rutledge FN. Second-look operation in ovarian carcinoma. Cancer 1976;38:1438-42.
15. Hee P, Pagel JD. Primary carcinoma of the fallopian tube. Eur J Obstet Gynecol Reprod Biol 1987;25:131-8.
16. Talamo TS, Bender BL, Ellis LD, Scioscia EA. Adenocarcinoma of the fallopian tube. An ultrastructural study. Virchows Arch [A] 1982;397:363-8.
17. Deppe G, Bruckner HW, Cohen CJ. Combination chemotherapy for advanced carcinoma of the fallopian tube. Obstet Gynecol 1980;56:530-2.
18. Williams CJ, Mead GM. Macbeth FR, et al. Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carci-noma: Mature results of a randomized trial J Clin Oncol 1985;3:1455-62.